1.Extracts of Monascusus purpureus beyond statins--profile of efficacy and safety of the use of extracts of Monascus purpureus.
Chinese journal of integrative medicine 2005;11(4):309-313
Extracts of Monascus purpureus have always been considered a natural source of lovastatin, the precursor of the world's largest selling class of drugs. In actual fact, the fungus contains many other substances (flavonoids, polyunsaturated fats, pyrrolinic compounds etc.) with a wide variety of other actions. The most recent studies have shown that it has an action on the glycemic metabolism, and on the mechanisms of adipogenesis, also an effects on the endothelium and on postprandial vasodilation. These effects are more extensive and complex than those of statins alone. And new strains of Monascus purpureus have recently been patented where the presence of statins is only one of the therapeutic components of the fungus. In particular, the increase in secondary components, such as flavonoids, which coincides with a more complex therapeutic action, probably making the new extracts of Monascus purpureus, the ideal candidate for the treatment of the metabolic syndrome.
Aged
;
Coronary Disease
;
drug therapy
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
therapeutic use
;
Monascus
;
Phytotherapy
;
Plant Extracts
;
therapeutic use
2.Benign intratesticular schwannoma: a rare finding.
Maria Chiara SIGHINOLFI ; Alessandro MOFFERDIN ; Stefano S De STEFANI ; Antonio CELIA ; Salvatore MICALI ; Giovanni SAREDI ; Giulio ROSSI ; Riccardo VALLI ; Giampaolo BIANCHI
Asian Journal of Andrology 2006;8(1):101-103
Schwannoma is a peripheral nerve tumour, occasionally located in the genitourinary tract. We described an extremely rare case of intratesticular neurinoma in a 79-year-old patient.
Aged
;
Humans
;
Male
;
Neurilemmoma
;
pathology
;
Testicular Neoplasms
;
pathology
3.Maxillary resection for cancer, zygomatic implants insertion, and palatal repair as single-stage procedure: report of three cases.
Pietro SALVATORI ; Antonio MINCIONE ; Lucio RIZZI ; Fabrizio COSTANTINI ; Alessandro BIANCHI ; Emma GRECCHI ; Umberto GARAGIOLA ; Francesco GRECCHI
Maxillofacial Plastic and Reconstructive Surgery 2017;39(5):13-
BACKGROUND: Oronasal/antral communication, loss of teeth and/or tooth-supporting bone, and facial contour deformity may occur as a consequence of maxillectomy for cancer. As a result, speaking, chewing, swallowing, and appearance are variably affected. The restoration is focused on rebuilding the oronasal wall, using either flaps (local or free) for primary closure, either prosthetic obturator. Postoperative radiotherapy surely postpones every dental procedure aimed to set fixed devices, often makes it difficult and risky, even unfeasible. Regular prosthesis, tooth-bearing obturator, and endosseous implants (in native and/or transplanted bone) are used in order to complete dental rehabilitation. Zygomatic implantology (ZI) is a valid, usually delayed, multi-staged procedure, either after having primarily closed the oronasal/antral communication or after left it untreated or amended with obturator. The present paper is an early report of a relatively new, one-stage approach for rehabilitation of patients after tumour resection, with palatal repair with loco-regional flaps and zygomatic implant insertion: supposed advantages are concentration of surgical procedures, reduced time of rehabilitation, and lowered patient discomfort. CASES PRESENTATION: We report three patients who underwent alveolo-maxillary resection for cancer and had the resulting oroantral communication directly closed with loco-regional flaps. Simultaneous zygomatic implant insertion was added, in view of granting the optimal dental rehabilitation. CONCLUSIONS: All surgical procedures were successful in terms of oroantral separation and implant survival. One patient had the fixed dental restoration just after 3 months, and the others had to receive postoperative radiotherapy; thus, rehabilitation timing was longer, as expected. We think this approach could improve the outcome in selected patients.
Congenital Abnormalities
;
Deglutition
;
Financing, Organized
;
Humans
;
Mastication
;
Prostheses and Implants
;
Radiotherapy
;
Rehabilitation
;
Tooth
4.Birth Weight and the Development of Functional Gastrointestinal Disorders in Infants
Maria Elisabetta BALDASSARRE ; Antonio Di MAURO ; Silvia SALVATORE ; Silvio TAFURI ; Francesco Paolo BIANCHI ; Enzo DATTOLI ; Lucia MORANDO ; Licia PENSABENE ; Fabio MENEGHIN ; Dario DILILLO ; Valentina MANCINI ; Valentina TALARICO ; Francesco TANDOI ; Gianvincenzo ZUCCOTTI ; Massimo AGOSTI ; Nicola LAFORGIA
Pediatric Gastroenterology, Hepatology & Nutrition 2020;23(4):366-376
Purpose:
To assess the association between birth weight and the development of functional gastrointestinal disorders (FGIDs) in the first year of life.
Methods:
This is a secondary analysis of a prospective cohort multicenter study including neonates, consecutively enrolled at birth, and followed up for one year. At birth all infants were classified by birth weight as extremely low (ELBW), very low, or low when <1,000, <1,500, and <2,500 g, respectively, and by birth weight for gestational age as appropriate (AGA, weight in the 10–90th percentile), small (SGA, weight <10th percentile), and large (LGA, weight >90th percentile) for gestational age. FGIDs were classified according to the Rome III criteria and assessed at 1, 3, 6, and 12 months of life.
Results:
Among 1,152 newborns enrolled, 934 (81.1%) completed the study: 302 (32.3%) were preterm, 35 (3.7%) were ELBW, 104 (11.1%) were SGA, 782 (83.7%) were AGA, and 48 (5.1%) were LGA infants. Overall, throughout the first year of life, 718 (76.9%) reported at least one FGID. The proportion of infants presenting with at least one FGID was significantly higher in ELBW (97%) compared to LBW (74%) (p=0.01) and in LGA (85.4%) and SGA (85.6%) compared to AGA (75.2%) (p=0.0001). On multivariate analysis, SGA was significantly associated with infantile colic.
Conclusion
We observed an increased risk of FGIDs in ELBW, SGA, and LGA neonates. Our results suggest that prenatal factors determining birth weight may influence the development of FGIDs in infants. Understanding the role of all potential risk factors may provide new insights and targeted approaches for FGIDs.